Primary liver cancer (HCC) is a kind of malignant tumor with high incidence in China. According to research and investigation, there are 854000 new cases of liver cancer worldwide every year, more than half of which occur in China. Liver cancer has the characteristics of high incidence, late detection, and difficult treatment, and it is easy to relapse and metastasize after operation. the 5-year survival rate is only 7% to 10%, and only a few people survive for a long time.
In recent years, some breakthroughs have been made in the drug treatment of liver cancer. In particular, the advent of immunotherapy to inhibit tumor growth by improving immunity has brought benefits to patients’ postoperative rehabilitation, countering the side effects of radiotherapy and chemotherapy, improving the quality of life, preventing recurrence and metastasis, and opening up a new situation in the field of liver cancer treatment. Improving immunity has become a top priority to stay away from cancer and cancer rehabilitation.
The low immunity of patients with liver cancer is mainly due to the decline of the body’s ability to resist infection caused by depletion, disability, and aging of T cells; secondly, radiotherapy or chemotherapy will also cause further damage to the immune function of patients with liver cancer, thus increasing the risk of infection. In addition, tumor patients often have a variety of malnutrition and may be associated with a variety of chronic diseases, which are more likely to have poor resistance.
So, how can patients with liver cancer improve their own immunity and improve their ability to recover from disease resistance?
At present, the improvement of autoimmunity is summarized into five ways: reasonable diet, balanced state of mind, regular work and rest, proper exercise, and immunomodulatory drug therapy.
Yangzheng Xiaoji ingredients include Radix Astragali, Ligustrum lucidum, ginseng, and other beneficial proprietary Chinese medicine, which can protect the relevant organs of the human body clinically, especially can effectively reduce the damage to white blood cells and can be involved in tumors. it has certain benefits for the treatment of tumors.
Yangzheng Xiaoji capsule has the efficacy of increasing efficacy, reducing toxicity, and regulating immunity. It can not only improve the efficacy of chemotherapeutic drugs in the treatment of primary liver cancer but also reduce the inhibition of hemoglobin, leukocytes, granulocytes, and platelets, reduce the level of glutamic pyruvic transaminase alkaline phosphatase and increase the proportion of NK cells.
Most patients with liver cancer are people with low immunity and anti-tumor therapy such as radiotherapy and chemotherapy will bring further damage to their immune function, coupled with malnutrition and other factors, liver cancer patients should pay more attention to the strengthening and recovery of immunity. Immunity can not only help the treatment of liver cancer but also resist the occurrence of all kinds of infections.
In recent years, with the development of immunotherapy, the mode of tumor therapy has gradually changed, and it also reflects the struggle between our immune system and tumors. The survival time of advanced patients is prolonged, and the 5-year survival rate continues to improve, which has brought a new breakthrough in the field of cancer treatment.
For patients with liver cancer, it is praiseworthy to improve their symptoms, improve their quality of life, and reduce the side effects of radiotherapy and chemotherapy. If conditions permit, traditional Chinese medicine, nutrition, and immunomodulatory therapy should be used as a red line in tumor treatment to provide a strong guarantee for improving patients’ quality of life and prolonging life.
